אומפרה 10

Nazione: Israele

Lingua: ebraico

Fonte: Ministry of Health

Principio attivo:

OMEPRAZOLE 10 MG

Commercializzato da:

RAFA LABORATORIES LTD

Codice ATC:

A02BC01

Forma farmaceutica:

CAPSULES

Via di somministrazione:

PER OS

Prodotto da:

LABORATORIOS LICONSA S.A., SPAIN

Gruppo terapeutico:

OMEPRAZOLE

Indicazioni terapeutiche:

Acute duodenal ulcer, Acute gastric ulcer, Helicobacter pylori associated peptic ulcer disease in combination with antibiotics. Reflux esophagitis: Treatment long-term management, Maintenance treatment for the prevention of relapse in patients with severe reflux esophagitis. Treatment of severe reflux esophagitis in children from one year of age and older. Maintenance treatment for the prevention of relapse in patients with poorly reponsive peptic ulcer. Zollinger-Ellison Syndrome. Treatment and prevention of NSAID-associated duodenal and gastric ulcer or erosions in high risk patients.

Data dell'autorizzazione:

2012-06-01